Changes in Skeletal Mineral in Patients on Prolonged Maintenance Dialysis

Atkinson, P. J.; Hancock, D. A.; Acharya, V. N.; Parsons, F. M.; Proctor, E. A.; Reed, G. W.
December 1973
British Medical Journal;12/1/1973, Vol. 4 Issue 5891, p519
Academic Journal
No abstract available.


Related Articles

  • Bone Mineral Density In Chronic Kidney Disease Patients. Akkupalli, Lalithamma; Paravathi, G.; Somasundaram, M.; Radha, J. Muni // International Journal of Biological & Medical Research;2013, Vol. 4 Issue 1, p2870 

    Background: Metabolic bone disease is common in the case of renal failure. The aim of this study is to compare mineral changes, hormonal changes and bone mineral density in predialysis and post-dialysis renal failure patients. Hypothesis: Secondary hyperparathyroidism may be the cause for...

  • Mineral and Bone Disorder Monitoring and Therapy.  // Indian Journal of Nephrology;Dec2012 Supplement, Vol. 22 Issue 7, pS40 

    The article discusses mineral and bone disorder monitoring and states that deranged mineral and bone metabolism and its treatment can lead to skeletal and extra skeletal, especially cardiovascular complications. It reports that it is important to identify and correct the abnormalities in...

  • Quality of life in renal failure.  // British Medical Journal;7/12/1980, Vol. 281 Issue 6233, p97 

    Focuses on the benefits of hemodialysis maintenance and renal transplantation in patients with renal failure. Description of hemodialysis treatment; Comparison of hemodialysis with renal transplantation; Advantages of technical changes in dialysis and transplantation in improving quality of...

  • Hemodialysis for Chronic Renal Failure: Medical, Moral and Ethical, and Socio-economic Problems. Schreiner, George E.; Maher, John F. // Annals of Internal Medicine;Mar65, Vol. 62 Issue 3, p551 

    Investigates the medical, ethical and socio-economic challenges of prolonged artificial maintenance of life in patients with chronic renal failure. Provision of an adequate trial of conservative management; Inadequacy of the resources of medical centers in the field of renal disease; Expansion...

  • Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Sheth, Rita D.; Perez, Maria D.; Goldstein, Stuart L. // Pediatric Nephrology;Aug2003, Vol. 18 Issue 8, p810 

    Cardiovascular disease is a major cause of morbidity and mortality in adult patients with end-stage renal disease receiving maintenance dialysis. Coronary artery calcifications (CAC) contribute to the high prevalence of cardiac disease and are associated with hyper-phosphatemia, an elevated...

  • Epidemiologic trends in chronic renal replacement therapy over forty years: A Swiss dialysis experience. Rhyn Lehmann, Petra; Amb�hl, Manon; Corleto, Domenica; Klaghofer, Richard; Amb�hl, Patrice M. // BMC Nephrology;2012, Vol. 13 Issue 1, p52 

    Background: Long term longitudinal data are scarce on epidemiological characteristics and patient outcomes in patients on maintenance dialysis, especially in Switzerland. We examined changes in epidemiology of patients undergoing renal replacement therapy by either hemodialysis or peritoneal...

  • Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrolgy Consortium study. Mitsnefes, Mark; Barletta, Gina; Dresner, Ian; Chand, Deepa; Geary, Denis; Lin, Jen-Jar; Patel, Hiren // Pediatric Nephrology;Aug2006, Vol. 21 Issue 8, p1167 

    Cross-sectional studies have demonstrated that left ventricular hypertrophy (LVH) is common in children on maintenance dialysis. We report the echocardiogram results of 17 children from seven centers in the Midwest Pediatric Nephrology Consortium who have spent at least 2 years on maintenance...

  • Insufficiency of PTH action on bone in uremia. Iwasaki, Y; Yamato, H; Nii-Kono, T; Fujieda, A; Uchida, M; Hosokawa, A; Motojima, M; Fukagawa, M // Kidney International Supplement;Jul2006, Issue 102, pS34 

    Abnormal bone turnover and mineral metabolism is observed in patients on dialysis. Secondary hyperparathyroidism (SHP) develops in response to mineral metabolism changes accompanying renal failure. As a factor of disease progression, the phenomenon of skeletal resistance to parathyroid hormone...

  • Disodium etidronate in hypercalcaemia due to immobilisation. Hagg, Erik; Eklund, Mikael; Torring, Ove // British Medical Journal (Clinical Research Edition);2/25/1984, Vol. 288 Issue 6417, p607 

    Examines the treatment with of disodium etidronate in patients with hypercalcaemia due to prolonged immobilization. Absence of change in urinary hydroxyproline secretion; Risk of developing osteomalacia; Prevention of bone mineral loss and hypercalcaemia in paraplegic patients.

  • Understanding Your New Life With Dialysis (Book). Leb, Daniel E. // Annals of Internal Medicine;Jul76, Vol. 85 Issue 1, p143 

    Reviews the book 'Understanding Your New Life With Dialysis. A Patient Guide for Physical and Physiological Adjustment to Maintenance Dialysis,' by Edith T. Oberley and Terry D. Oberly.


Read the Article

Other Topics